Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Vlasses

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
The American Journal of Cardiology|June 1, 1995
Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarctionJ M Yim, T J Hoon, N Bittar, et al.
Federation Proceedings|April 1, 1984
Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humansH H Rotmensch, M Vincent, P H Vlasses, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteersG J Gormley, E Stoner, R S Rittmaster, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Pharmacotherapy|November 1, 1985
Steady-state disposition of diflunisal: once- versus twice-daily administrationP Mojaverian, M L Rocci, B N Swanson, et al.
Journal of Cardiovascular Pharmacology|March 1, 1985
Initial evaluation of transdermal timolol: serum concentrations and beta-blockadeP H Vlasses, L G Ribeiro, H H Rotmensch, et al.
Journal of Clinical Pharmacology|August 1, 1984
Methyldopa does not alter the disposition of digoxinC A May, P H Vlasses, M L Rocci, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|June 1, 1995
Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarctionJ M Yim, T J Hoon, N Bittar, et al.
Federation Proceedings|April 1, 1984
Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humansH H Rotmensch, M Vincent, P H Vlasses, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteersG J Gormley, E Stoner, R S Rittmaster, et al.
Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.
Pharmacotherapy|November 1, 1985
Steady-state disposition of diflunisal: once- versus twice-daily administrationP Mojaverian, M L Rocci, B N Swanson, et al.
Journal of Cardiovascular Pharmacology|March 1, 1985
Initial evaluation of transdermal timolol: serum concentrations and beta-blockadeP H Vlasses, L G Ribeiro, H H Rotmensch, et al.
Journal of Clinical Pharmacology|August 1, 1984
Methyldopa does not alter the disposition of digoxinC A May, P H Vlasses, M L Rocci, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Pageof 17